Here are five things to know:
1. UHS operating income was $384.2 million (9.7% margin) for the third quarter of 2024, a 34.6% increase from $285.4 million (8% margin) in the same quarter last year.
2. Total revenue for UHS was $3.96 billion for the third quarter of 2024, an 11.2% increase from $3.56 billion in the third quarter of 2023.
3. UHS’ total operating expenses were $3.58 billion for the quarter, a 9.2% increase from $3.28 billion during the same period last year.
4. Long-term debt for the for-profit health system was $4.62 billion in the quarter, a 3.5% decrease from $4.79 billion last year.
5. Salaries, wages and benefits for UHS were $1.91 billion in the third quarter of 2024, up from $1.78 billion during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
